Cormedix Will Make Dialysis Much Safer and Healthier
Brian Wang, Nextbigfuture, interviewed Joseph Todicso, CEO of Cormedix. DefenCath™ is Cormedix formulation of taurolidine and heparin that will greatly reduce dialysis infections for those using catheter lock solutions. It is trying to greatly reduce the risk of catheter-related bloodstream infections (CRBSIs) from central venous catheters (CVCs). Cormedix is making solid progress for regulatory and …